About Scientific Commercialization
Scientific Commercialization is a company based in Madison (United States) founded in 2005 was acquired by The CM Group in February 2021. Scientific Commercialization operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
The CM Group
(Feb 16, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Scientific Commercialization
Detailed funding history for Scientific Commercialization
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Scientific Commercialization
Scientific Commercialization has secured backing from 1 investor. Prominent investors backing the company include The CM Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical meeting and marketing services for pharmaceuticals are provided.
|
Locked | Locked | Locked |
Investor details for Scientific Commercialization
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scientific Commercialization
Investment portfolio details for Scientific Commercialization
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scientific Commercialization
Detailed financials for Scientific Commercialization
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scientific Commercialization Comparisons
Peer comparison for Scientific Commercialization
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scientific Commercialization
Scientific Commercialization operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of Scientific Commercialization
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scientific Commercialization
Complete news archive for Scientific Commercialization
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scientific Commercialization
Scientific Commercialization was founded in 2005.
Scientific Commercialization is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Daniel Leonard is the current CEO of Scientific Commercialization.
Scientific Commercialization was founded in 2005 and is based in Madison, United States. Operations focus on the pharmaceutical sector, where consulting services and business intelligence are delivered to support commercialization efforts. Expertise is applied in areas such as market analysis and strategic advisory, serving clients in the life sciences industry. The company is led by CEO Daniel Leonard, with activities centered on data-driven insights for pharmaceutical development.
Scientific Commercialization's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Scientific Commercialization has 1 investor. Key investors include The CM Group.